Comunicati Stampa
Agricoltura

NRGene Achieves Full Clubroot Resistance in Canola and Moves Toward Commercialization in Canada

      Developed inSaskatchewan, this innovation brings long-term value to Canadian agriculture, strengthening the country's position as a global leader in sustainable crop development. Clubroot resistance trait development, IP protection, and all commercialization efforts are led by NRGene's wholly owned Canadian subsidiary, NRGene Green. Extensive field trials conducted in 2025 confirmed that NRGene's advanced introgressed donor lines achieved 0% disease incidence under high...
SASKATOON, SK, (informazione.news - comunicati stampa - agricoltura)

 

 

Developed in Saskatchewan , this innovation brings long-term value to Canadian agriculture, strengthening the country's position as a global leader in sustainable crop development. Clubroot resistance trait development, IP protection, and all commercialization efforts are led by NRGene's wholly owned Canadian subsidiary, NRGene Green.

Extensive field trials conducted in 2025 confirmed that NRGene's advanced introgressed donor lines achieved 0% disease incidence under high pathogen pressure, while existing industry-resistant varieties collapsed with disease infection rates exceeding 74%.

With Canada's canola industry valued at $43.7 billion annually, these results represent a transformational breakthrough for global oilseed production, offering Canadian farmers the first truly robust defense against clubroot (Plasmodiophora brassicae), which threatens billions in yield losses worldwide.

NRGene's 2025 field trials delivered exceptional results across multiple breeding lines:

"These results represent a global breakthrough in sustainable agriculture," said Dr. Masood Rizvi , General Manager of NRGene Green. "For the first time, farmers worldwide will have access to canola varieties that combine complete disease immunity with commercial viability, ensuring food security while driving long-term agricultural sustainability."

NRGene's clubroot-resistant germplasm represents next-generation crop breeding technology:

"This achievement demonstrates how AI-driven genomics combined with an in-depth biology understanding can solve agriculture's most challenging problems," said Gil Ronen , CEO of NRGene. "Our technology provides farmers and seed companies with the first truly effective solution to this global crisis while protecting both yields and the environment."

The resistant lines and molecular markers are now available for licensing to commercial breeding programs and seed companies worldwide. This opens high-value opportunities for seed companies to secure breakthrough resistance traits while equipping farmers with more resilient varieties. NRGene Green's royalty-based revenue model provides scalability and recurring income streams, creating a sustainable growth engine. With full compatibility across existing breeding programs, commercial integration can proceed rapidly, shortening the path from R&D to market-ready hybrids. NRGene Green is already collaborating with leading seed companies to integrate this innovation into elite pipelines.

NRGene Green's breakthrough in clubroot resistance positions the company as a global leader in agricultural innovation, addressing critical food security challenges while driving forward the next generation of climate-resilient, high-performance crops solutions.

NRGene Green, a wholly owned company of NRGene Ltd (TASE: NRGN), is dedicated to advancing oil-crops research and commercialization. By integrating AI-driven genomics and molecular breeding, NRGene Green develops and delivers innovative, high-performance canola and soybean traits to support seed companies and growers worldwide.

Logo - https://mma.prnewswire.com/media/2764633/NRGene_Green_Logo.jpg

Daphna Tako
Marketing Director

daphna.tako@nrgene.com

View original content:https://www.prnewswire.co.uk/news-releases/nrgene-achieves-full-clubroot-resistance-in-canola-and-moves-toward-commercialization-in-canada-302546597.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili